✦ LIBER ✦

The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor

✍ Scribed by Yoshimi Imura; Zen-ichi Tereshita; Yumiko Shibouta; Kohei Nishikawa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cv-4151 — a potent, selective thromboxan

✍ Z. Terashita; Y. Imura; M. Tanabe; K. Kawazoe; K. Nishikawa; K. Kato; S. Terao 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 960 KB

The synthesis of potent thromboxane A2/

✍ Nobuyuki Hamanaka; Takuya Seko; Tohru Miyazaki; Masao Naka; Kyoji Furuta; Hisash 📂 Article 📅 1989 🏛 Elsevier Science 🌐 French ⚖ 237 KB

In diseases such as angina pectoris and thrombosis, thromboxane Az(TXA2)

HA-29: An inhibitor of thromboxane A2 fo

✍ Chinn-Huang Lin; Sheng-Chu Kuo; Li-Jiau Huang; Tur-Fu Huang; Che-Ming Teng 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 818 KB

Effects of a thromboxane synthetase inhi

✍ Eugen H. O'Keefe; Edward C.K. Liu; Roland Greenberg; Martin L. Ogletree 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 701 KB

The F2-isoprostane, 8-epi-prostaglandin

✍ J.D. Morrow; T.A. Minton; L.J. Roberts II 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 476 KB

Delay of the initiation of hypertension

✍ Yumiko Shibouta; Zen-Ichi Terashita; Yoshiyuki Inada; Kohei Nishikawa 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 684 KB